Hirtle Callaghan & Co’s Sanofi SNY Stock Holding History

Hirtle Callaghan & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-852	Closed	-$39K	–	313
2014 Q4	$39K	Hold	852	–	–	0.01%	323
2014 Q3	$48K	Hold	852	–	–	0.01%	311
2014 Q2	$45K	Hold	852	–	–	0.01%	368
2014 Q1	$45K	Buy	852 +4	+0.5%	+$202	0.01%	362
2013 Q4	$45K	Buy	848 +12	+1%	+$619	0.01%	346
2013 Q3	$42K	Buy	+836	New	+$42.5K	0.01%	365

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Hirtle Callaghan & Co's SNY Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Sanofi (SNY) in Q1 2015, closing a stake of 852 shares — an estimated $39K sold.

Hirtle Callaghan & Co first reported a position in SNY in Q3 2013 and held it in 6 quarters. The position peaked at $48K in Q3 2014. 518 funds tracked by Wall St. Rank hold SNY as of Q1 2015.

Hirtle Callaghan & Co reported no remaining Sanofi position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 852 Sanofi shares in Q1 2015, an estimated $39K.
Hirtle Callaghan & Co first reported a position in Sanofi in Q3 2013 and held it in 6 quarters.
Hirtle Callaghan & Co's Sanofi position peaked at $48K in Q3 2014.
518 funds tracked by Wall St. Rank held Sanofi as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.